Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial’.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The IMID Forum
Discussing RA: Biologic effectiveness and treatment persistence in RA
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety
Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026
Discussing RA: Advanced therapy outcomes in RA
Get summaries like this every morning.
Free AI-powered recaps of The IMID Forum and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.